Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants

Abstract

Objective

To rank clinician-driven tests and treatments (CTTs) by their total cost during the birth hospitalization for preterm infants.

Study design

Retrospective cohort of very low birth weight (<1500 g) and/or very preterm (<32 weeks) subjects admitted to US children’s hospital Neonatal Intensive Care Units (2012–2018). CTTs were defined as pharmaceutical, laboratory and imaging services and ranked by total cost.

Results

24,099 infants from 51 hospitals were included. Parenteral nutrition ($85M, 32% of pharmacy costs), blood gas analysis ($34M, 29% of laboratory costs), and chest radiographs ($18M, 31% of imaging costs) were the costliest CTTs overall. More than half of CTT-related costs occurred during 10% of hospital days.

Conclusions

The majority of CTT-related costs were from commonly used tests and treatments. Targeted efforts to improve value in neonatal care may benefit most from focusing on reducing unnecessary utilization of common tests and treatments, rather than infrequently used ones.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D, et al. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166:1155–64.

    Article  Google Scholar 

  2. Dukhovny D, Pursley DM, Kirpalani HM, Horbar JH, Zupancic JA. Evidence, quality, and waste: solving the value equation in neonatology. Pediatrics. 2016;137:e20150312.

    Article  Google Scholar 

  3. Ho T, Zupancic JAF, Pursley DM, Dukhovny D. Improving value in neonatal intensive care. Clin Perinatol. 2017;44:617–25.

    Article  Google Scholar 

  4. Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–81.

    Article  CAS  Google Scholar 

  5. Wei D, Osman C, Dukhovny D, Romley J, Hall M, Chin S, et al. Cost consciousness among physicians in the neonatal intensive care unit. J Perinatol. 2016;36:1014–20.

    Article  CAS  Google Scholar 

  6. Ho T, Dukhovny D, Zupancic JA, Goldmann DA, Horbar JD, Pursley DM. Choosing wisely in newborn medicine: five opportunities to increase value. Pediatrics. 2015;136:e482–9.

    Article  Google Scholar 

  7. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.

    Article  Google Scholar 

  8. Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32:476–81.

    PubMed  Google Scholar 

  9. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–9.

    Article  CAS  Google Scholar 

  10. Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Serv Res. 2018;53:175–96.

    Article  Google Scholar 

  11. Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: Chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc. 1981;76:221–30.

    Article  Google Scholar 

  12. Richardson DK, Zupancic JA, Escobar GJ, Ogino M, Pursley DM, Mugford M. A critical review of cost reduction in neonatal intensive care. II. Strategies for reduction. J Perinatol. 2001;21:121–7.

    Article  CAS  Google Scholar 

  13. Arjaans S, Zwart EAH, Ploegstra MJ, Bos AF, Kooi EMW, Hillege HL, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2018;32:258–67.

    Article  Google Scholar 

  14. Sankar MN, Bhombal S, Benitz WE. PDA: To treat or not to treat. Congenit Heart Dis. 2019;14:46–51.

    Article  Google Scholar 

  15. Suresh G, King BC, Jain SK. Screening for pulmonary hypertension in preterm infants-not ready for prime time. J Perinatol. 2018;38:206–10.

    Article  Google Scholar 

  16. Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.

    PubMed  Google Scholar 

  17. Soll RF. Inhaled nitric oxide for preterm infants: what can change our practice? Pediatrics. 2018;141;e20174214.

    Article  Google Scholar 

  18. Kelly LE, Ohlsson A, Shah PS. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017;8:CD005494.

    Google Scholar 

  19. Ng G, Da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2016;12:CD003214.

    PubMed  Google Scholar 

  20. Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;9:CD001453.

    Google Scholar 

  21. Goodman DC, Ganduglia-Cazaban C, Franzini L, Stukel TA, Wasserman JR, Murphy MA, et al. Neonatal intensive care variation in medicaid-insured newborns: a population-based study. J Pediatr. 2019;209:44–51.e2.

    Article  Google Scholar 

  22. Kaplan HC, Tabangin ME, McClendon D, Meinzen-Derr J, Margolis PA, Donovan EF. Understanding variation in vitamin A supplementation among NICUs. Pediatrics. 2010;126:e367–73.

    Article  Google Scholar 

  23. Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013;131:716–23.

    Article  Google Scholar 

  24. Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. PLoS ONE. 2014;9:e106838.

    Article  Google Scholar 

  25. Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012;129:e945–51.

    Article  Google Scholar 

  26. Rogowski J. Using economic information in a quality improvement collaborative. Pediatrics. 2003;111:e411–8.

    PubMed  Google Scholar 

  27. Synhorst DC, Johnson MB, Bettenhausen JL, Kyler KE, Richardson TE, Mann KJ, et al. Room costs for common pediatric hospitalizations and cost-reducing quality initiatives. Pediatrics. 2020;145:e20192177.

    Article  Google Scholar 

  28. Phibbs CS, Schmitt SK, Cooper M, Gould JB, Lee HC, Profit J, et al. Birth hospitalization costs and days of care for mothers and neonates in California, 2009-2011. J Pediatr. 2019;204:118–25.e14.

    Article  Google Scholar 

  29. Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, Poschman K, et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007;120:e1–9.

    Article  Google Scholar 

  30. Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM, et al. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009;124:1325–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization/design/methodology and Manuscript editing: BCK, TR, MH, NAB, HCL, KSG, JLS, RMP, SWP. Investigation/formal analysis and Manuscript drafting: BCK, TR, JLS. All authors gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Brian C. King.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

King, B.C., Richardson, T., Patel, R.M. et al. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol 41, 295–304 (2021). https://doi.org/10.1038/s41372-020-00879-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-020-00879-6

This article is cited by

Search

Quick links